Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.

BACKGROUND: Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali. METHODS: Of 151...

Full description

Bibliographic Details
Main Authors: Graz, B, Dicko, M, Willcox, M, Lambert, B, Falquet, J, Forster, M, Giani, S, Diakite, C, Dembele, E, Diallo, D, Barennes, H
Format: Journal article
Language:English
Published: BioMed Central 2008
_version_ 1826259685978669056
author Graz, B
Dicko, M
Willcox, M
Lambert, B
Falquet, J
Forster, M
Giani, S
Diakite, C
Dembele, E
Diallo, D
Barennes, H
author_facet Graz, B
Dicko, M
Willcox, M
Lambert, B
Falquet, J
Forster, M
Giani, S
Diakite, C
Dembele, E
Diallo, D
Barennes, H
author_sort Graz, B
collection OXFORD
description BACKGROUND: Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali. METHODS: Of 151 patients with presumed severe malaria, 23 children with blood glucose concentrations < 60 mg/dl (< 3.3 mmol/l) were assigned randomly to receive either intravenous 10% glucose (IVG; n = 9) or sublingual sugar (SLS; n = 14). In SLS, a teaspoon of sugar, moistened with a few drops of water, was gently placed under the tongue every 20 minutes. The child was put in the recovery position. Blood glucose concentration (BGC) was measured every 5-10 minutes for the first hour. All children were treated for malaria with intramuscular artemether. The primary outcome measure was treatment response, defined as reaching a BGC of >or= 3.3 mmol/l (60 mg/dl) within 40 minutes after admission. Secondary outcome measures were early treatment response at 20 minutes, relapse (early and late), maximal BGC gain (CGmax), and treatment delay. RESULTS: There was no significant difference between the groups in the primary outcome measure. Treatment response occurred in 71% and 67% for SLS and IVG, respectively. Among the responders, relapses occurred in 30% on SLS at 40 minutes and in 17% on IVG at 20 minutes. There was one fatality in each group. Treatment failures in the SLS group were related to children with clenched teeth or swallowing the sugar, whereas in the IVG group, they were due to unavoidable delays in beginning an infusion (median time 17.5 min (range 3-40).Among SLS, the BGC increase was rapid among the nine patients who really kept the sugar sublingually. All but one increased their BGC by 10 minutes with a mean gain of 44 mg/dl (95%CI: 20.5-63.4). CONCLUSION: Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising method of raising blood glucose in severely ill children. More frequent repeated doses are needed to prevent relapse. Children should be monitored for early swallowing which leads to delayed absorption, and in this case another dose of sugar should be given. Sublingual sugar could be proposed as an immediate "first aid" measure while awaiting intravenous glucose. In many cases it may avert the need for intravenous glucose.
first_indexed 2024-03-06T18:53:43Z
format Journal article
id oxford-uuid:111e068c-3087-4d7b-a4f5-11c3606ed45f
institution University of Oxford
language English
last_indexed 2024-03-06T18:53:43Z
publishDate 2008
publisher BioMed Central
record_format dspace
spelling oxford-uuid:111e068c-3087-4d7b-a4f5-11c3606ed45f2022-03-26T10:00:23ZSublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:111e068c-3087-4d7b-a4f5-11c3606ed45fEnglishSymplectic Elements at OxfordBioMed Central2008Graz, BDicko, MWillcox, MLambert, BFalquet, JForster, MGiani, SDiakite, CDembele, EDiallo, DBarennes, H BACKGROUND: Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali. METHODS: Of 151 patients with presumed severe malaria, 23 children with blood glucose concentrations < 60 mg/dl (< 3.3 mmol/l) were assigned randomly to receive either intravenous 10% glucose (IVG; n = 9) or sublingual sugar (SLS; n = 14). In SLS, a teaspoon of sugar, moistened with a few drops of water, was gently placed under the tongue every 20 minutes. The child was put in the recovery position. Blood glucose concentration (BGC) was measured every 5-10 minutes for the first hour. All children were treated for malaria with intramuscular artemether. The primary outcome measure was treatment response, defined as reaching a BGC of >or= 3.3 mmol/l (60 mg/dl) within 40 minutes after admission. Secondary outcome measures were early treatment response at 20 minutes, relapse (early and late), maximal BGC gain (CGmax), and treatment delay. RESULTS: There was no significant difference between the groups in the primary outcome measure. Treatment response occurred in 71% and 67% for SLS and IVG, respectively. Among the responders, relapses occurred in 30% on SLS at 40 minutes and in 17% on IVG at 20 minutes. There was one fatality in each group. Treatment failures in the SLS group were related to children with clenched teeth or swallowing the sugar, whereas in the IVG group, they were due to unavoidable delays in beginning an infusion (median time 17.5 min (range 3-40).Among SLS, the BGC increase was rapid among the nine patients who really kept the sugar sublingually. All but one increased their BGC by 10 minutes with a mean gain of 44 mg/dl (95%CI: 20.5-63.4). CONCLUSION: Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising method of raising blood glucose in severely ill children. More frequent repeated doses are needed to prevent relapse. Children should be monitored for early swallowing which leads to delayed absorption, and in this case another dose of sugar should be given. Sublingual sugar could be proposed as an immediate "first aid" measure while awaiting intravenous glucose. In many cases it may avert the need for intravenous glucose.
spellingShingle Graz, B
Dicko, M
Willcox, M
Lambert, B
Falquet, J
Forster, M
Giani, S
Diakite, C
Dembele, E
Diallo, D
Barennes, H
Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title_full Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title_fullStr Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title_full_unstemmed Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title_short Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
title_sort sublingual sugar for hypoglycaemia in children with severe malaria a pilot clinical study
work_keys_str_mv AT grazb sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT dickom sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT willcoxm sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT lambertb sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT falquetj sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT forsterm sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT gianis sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT diakitec sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT dembelee sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT diallod sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy
AT barennesh sublingualsugarforhypoglycaemiainchildrenwithseveremalariaapilotclinicalstudy